Trends in the use of psychotropic drugs in Taiwan: A population-based national health insurance study, 1997-2004

被引:39
作者
Chien, Chia
Bih, Shin-Huey
Chou, Yiing-Jenq
Lin, Ching-Heng
Lee, Wen-Guang
Chou, Pesus
机构
[1] Jianan Mental Hosp, Tainan 71742, Taiwan
[2] Chia Nan Univ Pharam & Sci, Dept Continuing Educ, Tainan, Taiwan
[3] Bali Psychiat Ctr, Dept Child & Adolescent Psychiat, Taipei, Taiwan
[4] Natl Yang Ming Univ, Dept Social Med, Taipei 112, Taiwan
[5] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan
[6] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan
[7] Jianan Mental Hosp, Dept Pharm, Tainan, Taiwan
关键词
OFF-LABEL USE; PSYCHIATRIC-DISORDERS; MEDICATION USE; PREVALENCE;
D O I
10.1176/appi.ps.58.4.554
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: This study examined changes in the use of psychotropic agents in Taiwan between 1997 and 2004. Methods: The population-based National Health Insurance database was used to detect trends in the use of psychotropic drugs in Taiwan. A dynamic random sample of 200,432 persons was gathered and followed from 1997 to 2004. Persons in the sample who had made at least one service claim during these years for either ambulatory or inpatient care with a psychotropic drug prescription were identified. Results: The prevalence of any psychotropic drug use increased from 7.1% in 1997 to 12.0% in 2004. The changes in prevalence of use of four kinds of psychotropic drugs from 1997 to 2004 were as follows: antipsychotics, 3.4% to 3.7%, although this finding was not significant; antidepressants, 2.2% to 4.4% (p <.001); mood stabilizers,.6% to 1.3% (p <.001); and anxiolytichypnotic drugs, 3.0% to 7.3% (p <.001). Conclusions: Overall, the prevalence of use of three kinds of psychotropic drugs (antidepressants, mood stabilizers, and anxiolytic-hypnotic drugs) increased greatly from 1997 to 2004.
引用
收藏
页码:554 / 557
页数:4
相关论文
共 15 条
[1]  
Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55
[2]   Side effects of atypical antipsychotic drugs [J].
Ananth, J ;
Parameswaran, S ;
Gunatilake, S .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (18) :2219-2229
[3]  
Aparasu Rajender R, 2005, Ann Clin Psychiatry, V17, P147, DOI 10.1080/10401230591002084
[4]   Psychotropic Medication Use in Canada [J].
Beck, Cynthia A. ;
Williams, Jeanne V. A. ;
Wang, Jian Li ;
Kassam, Aliya ;
El-Guebaly, Nady ;
Currie, Shawn R. ;
Maxwell, Colleen J. ;
Patten, Scott B. .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (10) :605-613
[5]   Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan [J].
Chien, IC ;
Chou, YJ ;
Lin, CH ;
Bih, SH ;
Chou, P .
PSYCHIATRIC SERVICES, 2004, 55 (06) :691-697
[6]   A survey of the off-label use of mood stabilizers in a large psychiatric hospital [J].
Haw, C ;
Stubbs, J .
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (04) :402-407
[7]   Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan [J].
Huang, WF ;
Lai, IC .
DRUGS & AGING, 2005, 22 (11) :957-965
[8]   PREVALENCE OF PSYCHIATRIC-DISORDERS IN TAIWAN DEFINED BY THE CHINESE DIAGNOSTIC INTERVIEW SCHEDULE [J].
HWU, HG ;
YEH, EK ;
CHANG, LY .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 79 (02) :136-147
[9]   Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication [J].
Kessler, RC ;
Berglund, P ;
Demler, O ;
Jin, R ;
Walters, EE .
ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (06) :593-602
[10]   Mental health-related drug utilization among older adults - Prevalence, trends, and costs [J].
Mamdani, M ;
Rapoport, M ;
Shulman, KI ;
Herrmann, N ;
Rochon, PA .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (10) :892-900